Sale!

Cardiac Channelopathy Gene Panel Test

Original price was: 9,600 د.إ.Current price is: 7,200 د.إ.

-25%

The Cardiac Channelopathy Gene Panel Test is a specialized diagnostic tool designed to detect genetic mutations associated with cardiac channelopathies, a group of disorders that affect the heart’s electrical activity and can lead to arrhythmias and sudden cardiac death. This comprehensive test examines multiple genes known to be involved in these conditions, providing crucial information for accurate diagnosis, management, and familial risk assessment.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test leverages advanced sequencing technologies to ensure high sensitivity and specificity. With a cost of 7200 AED, it represents a significant investment in personal health, offering insights that can guide preventive measures, treatment decisions, and inform family members about their potential risks. The results from this test can be pivotal in developing personalized management plans for individuals with or at risk of cardiac channelopathies, ultimately aiming to improve outcomes and reduce the risk of life-threatening cardiac events.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Cardiac Channelopathy Gene Panel Test

Cost: 7200.0 AED

Symptoms, Diagnosis, and Test Details

The Cardiac Channelopathy Gene Panel Test is a genetic test that analyzes a group of genes associated with cardiac channelopathies. These inherited heart conditions affect the electrical signaling in the heart and can lead to abnormal heart rhythms, fainting, and sudden cardiac arrest.

The panel typically includes genes associated with long QT syndrome, short QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT). These conditions are caused by mutations in genes that encode ion channels or associated proteins involved in regulating ion channels in the heart.

The Cardiac Channelopathy Gene Panel Test can help identify individuals who may be at risk for these conditions, allowing for earlier diagnosis and treatment. It may also be used for family members of affected individuals to determine if they carry the same genetic mutation and are at risk for developing the condition.

Test Components

  • Sterile container
  • Sterile Normal Saline Container
  • EDTA Vacutainer

Sample Condition

Amniotic fluid, Chorionic villi, Peripheral blood

Report Delivery

4-6 weeks

Method

Next-Generation Sequencing (NGS)

Test Type

Genetics

Doctor

General Physician

Test Department

Pre Test Information

The Cardiac Channelopathy Gene Panel Test requires a doctor’s prescription. However, it is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Name Cardiac Channelopathy Gene Panel Test
Components Sterile container/ Sterile Normal Saline Container/ EDTA Vacutainer
Price 7200.0 AED
Sample Condition Amniotic fluid\/ Chorionic villi\/ Peripheral blood
Report Delivery 4-6 weeks
Method NGS
Test type Genetics
Doctor General Physician
Test Department:
Pre Test Information Cardiac Channelopathy Gene Panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

The Cardiac Channelopathy Gene Panel is a genetic test that analyzes a group of genes associated with cardiac channelopathies. These are a group of inherited heart conditions that affect the electrical signaling in the heart and can lead to abnormal heart rhythms, fainting, and sudden cardiac arrest.

The panel typically includes genes associated with long QT syndrome, short QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT). These conditions can be caused by mutations in genes that encode ion channels or associated proteins involved in regulating ion channels in the heart.

The Cardiac Channelopathy Gene Panel can help identify individuals who may be at risk for these conditions, allowing for earlier diagnosis and treatment. It may also be used for family members of affected individuals to determine if they carry the same genetic mutation and are at risk for developing the condition.